Heartflow (NASDAQ:HTFL) Hits New 52-Week High – Time to Buy?

Heartflow, Inc. (NASDAQ:HTFL)’s stock price reached a new 52-week high on Wednesday. The stock traded as high as $60.66 and last traded at $60.0040, with a volume of 852,071 shares changing hands. The stock had previously closed at $55.80.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the company. Piper Sandler restated an “overweight” rating and set a $64.00 target price (up from $45.00) on shares of Heartflow in a report on Tuesday, October 20th. Stifel Nicolaus increased their price target on shares of Heartflow from $40.00 to $45.00 and gave the company a “buy” rating in a research report on Friday, August 14th. Wall Street Zen downgraded shares of Heartflow from a “buy” rating to a “hold” rating in a research report on Saturday. Weiss Ratings reissued a “sell (d-)” rating on shares of Heartflow in a research note on Wednesday, November 4th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Heartflow from $35.00 to $45.00 and gave the company an “overweight” rating in a report on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $48.62.

Heartflow Price Performance

The company has a market cap of $5.18 billion, a price-to-earnings ratio of -32.67 and a beta of 2.50. The stock has a 50-day moving average price of $51.56 and a 200 day moving average price of $34.87.

Heartflow (NASDAQ:HTFL) last issued its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%. The business had revenue of $64.08 million during the quarter. The company’s revenue was up 47.7% on a year-over-year basis. Sell-side analysts expect that Heartflow, Inc. will post -0.75 EPS for the current fiscal year.

Insider Buying and Selling at Heartflow

In other news, CEO John Farquhar sold 38,900 shares of the stock in a transaction on Monday, October 12th. The shares were sold at an average price of $49.57, for a total transaction of $1,928,273.00. Following the completion of the sale, the chief executive officer owned 283,014 shares of the company’s stock, valued at $14,029,003.98. This represents a 12.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Vikram Verghese sold 29,714 shares of the firm’s stock in a transaction on Friday, September 11th. The stock was sold at an average price of $50.06, for a total transaction of $1,487,482.84. Following the sale, the chief financial officer owned 184,789 shares in the company, valued at approximately $9,250,537.34. The trade was a 13.85% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 347,963 shares of company stock valued at $17,210,559. 7.70% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Heartflow

Large investors have recently added to or reduced their stakes in the company. XXEC Inc. acquired a new position in shares of Heartflow during the second quarter worth about $2,524,764,000. Quantinno Capital Management LP bought a new position in shares of Heartflow during the first quarter worth about $1,734,000. Sei Investments Co. raised its position in Heartflow by 342.5% in the 1st quarter. Sei Investments Co. now owns 67,048 shares of the company’s stock valued at $1,631,000 after buying an additional 51,895 shares during the last quarter. Bank of New York Mellon Corp acquired a new stake in Heartflow in the 2nd quarter valued at approximately $19,096,000. Finally, Handelsbanken Fonder AB bought a new stake in Heartflow in the 2nd quarter valued at approximately $910,000.

Heartflow Company Profile

HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.